Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0237
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Organ Weight / Spleen weight
|
HOM
|
10f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.388
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.510
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.994
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Lymphocyte cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Lymphocyte cell count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.362
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Hematocrit
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Hematocrit
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00554
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Monocyte cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Monocyte cell count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0653
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000121
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.303
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Eosinophil cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Eosinophil cell count
|
HOM
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.261
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / White blood cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / White blood cell count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.492
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00180
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Red blood cell distribution width
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Red blood cell distribution width
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
1.46×10-09
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
6f:8m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Neutrophil differential count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Neutrophil differential count
|
HOM
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0132
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
3.94×10-08
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean platelet volume
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean platelet volume
|
HOM
|
13f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.601
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Basophil differential count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Basophil differential count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.215
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Platelet count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Platelet count
|
HOM
|
13f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.000929
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Lymphocyte differential count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Lymphocyte differential count
|
HOM
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.000546
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0688
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0810
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Monocyte differential count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Monocyte differential count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.000475
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.398
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Hemoglobin
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Hemoglobin
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.00136
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean cell volume
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Mean cell volume
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.200
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Eosinophil differential count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Eosinophil differential count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.478
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000384
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Red blood cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Red blood cell count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0635
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Basophil cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Basophil cell count
|
HOM
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.457
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
9.60×10-07
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Neutrophil cell count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Neutrophil cell count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.752
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Vps13ctm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
14f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.688
|
Successful |
Vps13ctm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.266
|
Successful |